Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+13.64%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$59.3B
AUM Growth
+$5.38B
(+10%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
30.78%
Holding
971
New
135
Increased
326
Reduced
323
Closed
128
Top Buys
| 1 |
Capital One
COF
|
$120M |
| 2 |
CSX Corp
CSX
|
$120M |
| 3 |
Amazon
AMZN
|
$120M |
| 4 |
Johnson Controls International
JCI
|
$114M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$108M |
Top Sells
| 1 |
3M
MMM
|
$169M |
| 2 |
DFS
Discover Financial Services
DFS
|
$163M |
| 3 |
WESCO International
WCC
|
$144M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$139M |
| 5 |
Royal Caribbean
RCL
|
$130M |
Sector Composition
| 1 | Technology | 29.16% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Mercado Libre
MELI
$123B
| $2.61M | ﹤0.01% |
+1,000
| New | +$2.61M |
|
752
Fortune Brands Innovations
FBIN
$7.3B
| $2.6M | ﹤0.01% |
50,500
-260,000
| -84% | -$13.4M |
|
753
Dow Inc
DOW
$17.4B
| $2.58M | ﹤0.01% |
97,400
-245,000
| -72% | -$6.49M |
|
754
Weatherford International
WFRD
$4.49B
| $2.52M | ﹤0.01% |
+50,000
| New | +$2.52M |
|
|
AARD
755
Aardvark Therapeutics, Inc. Common Stock
AARD
$187M
| $2.37M | ﹤0.01% |
175,000
-75,000
| -30% | -$1.01M |
|
756
Chemed
CHE
$6.79B
| $2.19M | ﹤0.01% |
+4,500
| New | +$2.19M |
|
757
Tourmaline Bio
TRML
$687M
| $2.17M | ﹤0.01% |
135,637
-364,363
| -73% | -$5.83M |
|
|
AIV
758
Aimco
AIV
$1.11B
| $2.16M | ﹤0.01% |
+250,000
| New | +$2.16M |
|
759
Avery Dennison
AVY
$13.1B
| $2.04M | ﹤0.01% |
11,600
-140,536
| -92% | -$24.7M |
|
|
FLOC
760
Flowco Holdings Inc.
FLOC
$400M
| $1.98M | ﹤0.01% |
111,199
-147,224
| -57% | -$2.62M |
|
761
Enliven Therapeutics
ELVN
$1.19B
| $1.93M | ﹤0.01% |
96,000
-354,000
| -79% | -$7.1M |
|
762
Sana Biotechnology
SANA
$752M
| $1.92M | ﹤0.01% |
+702,000
| New | +$1.92M |
|
763
Shutterstock
SSTK
$713M
| $1.9M | ﹤0.01% |
100,000
| – | – |
|
|
AII
764
American Integrity Insurance Group, Inc.
AII
$385M
| $1.88M | ﹤0.01% |
+102,342
| New | +$1.88M |
|
765
Rollins
ROL
$27.4B
| $1.83M | ﹤0.01% |
32,450
-3,900
| -11% | -$220K |
|
766
Karyopharm Therapeutics
KPTI
$57.2M
| $1.82M | ﹤0.01% |
421,322
| – | – |
|
|
CRCL
767
Circle Internet Group, Inc.
CRCL
$26.5B
| $1.81M | ﹤0.01% |
+10,000
| New | +$1.81M |
|
768
Campbell Soup
CPB
$10.1B
| $1.75M | ﹤0.01% |
57,246
-122,300
| -68% | -$3.75M |
|
769
Novartis
NVS
$251B
| $1.75M | ﹤0.01% |
+14,481
| New | +$1.75M |
|
770
Fidelis Insurance
FIHL
$1.83B
| $1.69M | ﹤0.01% |
+101,764
| New | +$1.69M |
|
771
Klaviyo
KVYO
$9.66B
| $1.68M | ﹤0.01% |
50,000
-25,000
| -33% | -$840K |
|
|
XIFR
772
XPLR Infrastructure, LP
XIFR
$976M
| $1.64M | ﹤0.01% |
+200,000
| New | +$1.64M |
|
|
CBIO
773
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $1.63M | ﹤0.01% |
100,912
+50,000
| +98% | +$807K |
|
774
Arch Capital
ACGL
$34.1B
| $1.53M | ﹤0.01% |
16,800
-400,300
| -96% | -$36.4M |
|
775
Financial Select Sector SPDR Fund
XLF
$53.2B
| $1.52M | ﹤0.01% |
+29,000
| New | +$1.52M |
|